Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Duffy

Showing results (51-60 of 600) with videos related to

Pageof 60
Sort By:
The Lancet. Oncology|November 5, 2020
Mammography screening for breast cancer-the UK Age trial - Authors' replyStephen W Duffy, Peter D Sasieni
The New England Journal of Medicine|January 30, 2020
Mortality Reduction with Low-Dose CT Screening for Lung CancerStephen W Duffy, John K Field
Journal of Cancer Epidemiology and Prevention|July 9, 2003
Cross-issue synthesis: potential application to breast cancer, tamoxifen and genetic susceptibilityR M Nixon, S W Duffy
The Medical Clinics of North America|October 25, 2020
The Evaluation of Cancer Screening: Concepts and Outcome MeasuresStephen W Duffy, Robert A Smith
Journal of Medical Screening|December 13, 2021
When primary prevention replaces screeningStephen W Duffy, Nicholas J Wald
Addiction (Abingdon, England)|June 1, 1994
Misinterpretation of published resultsS W Duffy, L D Sharples
The British Journal of Radiology|September 1, 1995
Comparison of single reading with double reading of mammograms, and change in effectiveness with experienceR M Warren, S W Duffy
British Journal of Cancer|March 1, 2002
Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutationsS W Duffy, R M Nixon
Journal of Medical Screening|March 14, 2015
A note on the design of cancer screening trialsStephen W Duffy, Robert A Smith
Thorax|June 30, 2018
Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?John K Field, Stephen W Duffy
Pageof 60

Showing results (51-60 of 600) with videos related to

Sort By:
Pageof 60
The Lancet. Oncology|November 5, 2020
Mammography screening for breast cancer-the UK Age trial - Authors' replyStephen W Duffy, Peter D Sasieni
The New England Journal of Medicine|January 30, 2020
Mortality Reduction with Low-Dose CT Screening for Lung CancerStephen W Duffy, John K Field
Journal of Cancer Epidemiology and Prevention|July 9, 2003
Cross-issue synthesis: potential application to breast cancer, tamoxifen and genetic susceptibilityR M Nixon, S W Duffy
The Medical Clinics of North America|October 25, 2020
The Evaluation of Cancer Screening: Concepts and Outcome MeasuresStephen W Duffy, Robert A Smith
Journal of Medical Screening|December 13, 2021
When primary prevention replaces screeningStephen W Duffy, Nicholas J Wald
Addiction (Abingdon, England)|June 1, 1994
Misinterpretation of published resultsS W Duffy, L D Sharples
The British Journal of Radiology|September 1, 1995
Comparison of single reading with double reading of mammograms, and change in effectiveness with experienceR M Warren, S W Duffy
British Journal of Cancer|March 1, 2002
Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutationsS W Duffy, R M Nixon
Journal of Medical Screening|March 14, 2015
A note on the design of cancer screening trialsStephen W Duffy, Robert A Smith
Thorax|June 30, 2018
Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?John K Field, Stephen W Duffy
Pageof 60